» Articles » PMID: 24510096

Rapid Identification of Regulatory MicroRNAs by MiTRAP (miRNA Trapping by RNA in Vitro Affinity Purification)

Overview
Specialty Biochemistry
Date 2014 Feb 11
PMID 24510096
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) control gene expression at the post-transcriptional level. However, the identification of miRNAs regulating the fate of a specific messenger RNA remains limited due to the imperfect complementarity of miRNAs and targeted transcripts. Here, we describe miTRAP (miRNA trapping by RNA in vitro affinity purification), an advanced protocol of previously reported MS2-tethering approaches. MiTRAP allows the rapid identification of miRNAs targeting an in vitro transcribed RNA in cell lysates. Selective co-purification of regulatory miRNAs was confirmed for the MYC- as well as ZEB2-3'UTR, two well-established miRNA targets in vivo. Combined with miRNA-sequencing, miTRAP identified in addition to miRNAs reported to control MYC expression, 18 novel candidates including not in silico predictable miRNAs. The evaluation of 10 novel candidate miRNAs confirmed 3'UTR-dependent regulation of MYC expression as well as putative non-canonical targeting sites for the not in silico predictable candidates. In conclusion, miTRAP provides a rapid, cost-effective and easy-to-handle protocol allowing the identification of regulatory miRNAs for RNAs of choice in a cellular context of interest. Most notably, miTRAP not only identifies in silico predictable but also unpredictable miRNAs regulating the expression of a specific target RNA.

Citing Articles

Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.

Wang Y, Lazaridou M, Kordass T, Massa C, Vaxevanis C, Eichmuller S Clin Transl Med. 2024; 14(10):e70010.

PMID: 39439221 PMC: 11496566. DOI: 10.1002/ctm2.70010.


Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy.

Vaxevanis C, Bachmann M, Seliger B J Immunother Cancer. 2024; 12(8).

PMID: 39209767 PMC: 11367391. DOI: 10.1136/jitc-2024-009774.


Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.

Pan Y, Cengiz R, Kluiver J, Diepstra A, van den Berg A Cancers (Basel). 2024; 16(6).

PMID: 38539461 PMC: 10968648. DOI: 10.3390/cancers16061126.


IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.

Hagemann S, Misiak D, Bell J, Fuchs T, Lederer M, Bley N Mol Cancer. 2023; 22(1):88.

PMID: 37246217 PMC: 10226260. DOI: 10.1186/s12943-023-01792-0.


Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanoma.

Vaxevanis C, Friedrich M, Tretbar S, Handke D, Wang Y, Blumke J Clin Transl Med. 2022; 12(7):e934.

PMID: 35802807 PMC: 9270002. DOI: 10.1002/ctm2.934.


References
1.
Meyer N, Penn L . Reflecting on 25 years with MYC. Nat Rev Cancer. 2008; 8(12):976-90. DOI: 10.1038/nrc2231. View

2.
Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S . p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A. 2009; 106(9):3207-12. PMC: 2651330. DOI: 10.1073/pnas.0808042106. View

3.
Cambronne X, Shen R, Auer P, Goodman R . Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach. Proc Natl Acad Sci U S A. 2012; 109(50):20473-8. PMC: 3528561. DOI: 10.1073/pnas.1218887109. View

4.
Robinson M, Oshlack A . A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010; 11(3):R25. PMC: 2864565. DOI: 10.1186/gb-2010-11-3-r25. View

5.
Wilson J, Huys A . miR-122 promotion of the hepatitis C virus life cycle: sound in the silence. Wiley Interdiscip Rev RNA. 2013; 4(6):665-76. DOI: 10.1002/wrna.1186. View